The Link Between Periodontitis, Smoking and Oral Cancer

NCT ID: NCT04047212

Last Updated: 2021-06-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-08-12

Study Completion Date

2032-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Periodontitis is a widely prevalent disease worldwide that has serious public health consequences. Its prognosis includes tooth loss and edentulism, a condition that negatively affects chewing causing functional disability; and esthetics causing social impairment. Consequently, periodontitis may end up causing marked impairment of the quality of life of the affected patients, impairment of general health and increasing the dental care costs significantly.

Changes in the oral mucosa arise by primary products resulting from tissue breakdown due to gingivitis. It then triggers the host cells to produce proteinases that mediate loss of marginal periodontal ligaments, apical migration of the junctional epithelium and apical spread of bacterial biofilm.

Therefore, this research aims to identify the risk of smoking to both periodontitis and oral cancer, and the risk of periodontitis to oral cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Periodontitis Oral Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Smokers

biopsy for oral cancer

Intervention Type DIAGNOSTIC_TEST

surgical biopsy is to be taken for diagnosis of oral cancer or premalignant lesions

periodontal examination

Intervention Type DIAGNOSTIC_TEST

Periodontal clinical examination to all by periodontal charting

non-Smokers

biopsy for oral cancer

Intervention Type DIAGNOSTIC_TEST

surgical biopsy is to be taken for diagnosis of oral cancer or premalignant lesions

periodontal examination

Intervention Type DIAGNOSTIC_TEST

Periodontal clinical examination to all by periodontal charting

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

biopsy for oral cancer

surgical biopsy is to be taken for diagnosis of oral cancer or premalignant lesions

Intervention Type DIAGNOSTIC_TEST

periodontal examination

Periodontal clinical examination to all by periodontal charting

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients 18 years or older.

Exclusion Criteria

* Patients with any systemic diseases.
* Pregnant females.
* Handicapped and mentally retarded patients.
* Patients undergoing radiotherapy.
* Patients having oral cancer
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ayat Gamal-AbdelNaser

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cairo University

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ayat Gamal-AbdelNaser

Role: CONTACT

01001874257

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ayat A Gamal-AbdelNaser

Role: primary

01001874257

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P12

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.